By continuing to browse our website, you agree to the storing of first- and third-party cookies and related technologies on your device to enhance site access and navigation, analyze site usage, authenticate users, facilitate transactions, and assist in our marketing efforts. Please read our privacy notice to learn more.
UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Recurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19

(JAMA) Recurrence of symptoms after finishing treatment for COVID-19 with nirmatrelvir-ritonavir (Paxlovid) has become increasingly recognized.13 The biological underpinning of this phenomenon is unclear, and its etiology may be multifactorial, including rapid clearance of nirmatrelvir coupled with delayed immune responses or possible development of drug resistance.13 The contribution of treatment to symptom rebound needs to be differentiated from symptom rebound that might occur during the natural history of COVID-19. In this cohort study, we sought to determine how often COVID-19 symptoms recurred when the disease was untreated.

twitter facebook bluesky email print

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.